Sports-medicine review finds external validation remains uncommon

The customer problem is deciding whether an appealing prediction tool is suitable for an actual sports-medicine decision. Engage the team physician, athletic trainers, performance staff, IT and procurement. Ask what action a risk score would change, what the current baseline achieves, and whether a vendor has tested comparable athletes prospectively. Offer a bounded evidence and data-readiness assessment before any clinical pilot. The value hypothesis is avoiding unsuitable integration and focusing evaluation effort. The review supplies questions for diligence, not a local injury-reduction estimate. Do not equate a high benchmark score with safer return-to-play decisions or guaranteed reductions in care costs.

Fit is a clinician-supervised validation environment using authorized representative data. Prerequisites include clear outcome definitions, timestamped features, an approved comparison process and access to model documentation. Prevent leakage by separating athletes and future periods appropriately; assess calibration, subgroup errors and decision consequences rather than accuracy alone. Test missing inputs, stale readings and distribution changes. Treat any LLM explanations as a separate component needing factual review. Cloud, local and hybrid designs all require enforceable health-data boundaries. A proof of value should remain disconnected from treatment changes until medical and institutional review approve a prospective protocol.

The sports-medicine director should own the decision workflow, with athletic trainers, a statistician and data engineers supporting validation. Establish the baseline, document data quality, run a shadow assessment and review errors before proposing supervised use. Dependencies include consent or other institutionally approved authority, reliable records and protected staff time. Train users to recognize uncertain outputs and record overrides. Governance checkpoints should approve data intake, evaluation design and model updates. Proposed acceptance criteria include complete provenance, no critical access failures, documented subgroup evaluation and medical sign-off on any progression. Small samples and changing practice patterns can invalidate apparently favorable results.